# Long-Term Safety Study of Tafenoquine

> **NCT03320174** · PHASE2 · COMPLETED · sponsor: **60 Degrees Pharmaceuticals LLC** · enrollment: 600 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Tafenoquine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03320174
- **Lead sponsor:** 60 Degrees Pharmaceuticals LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-05
- **Primary completion:** 2021-07-13
- **Final completion:** 2021-07-13
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03320174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03320174, "Long-Term Safety Study of Tafenoquine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03320174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*